Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Uxin (UXIN) EBT (2017 - 2025)

Uxin filings provide 9 years of EBT readings, the most recent being -$11.8 million for Q4 2025.

  • On a quarterly basis, EBT rose 4.34% to -$11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.6 billion, a 54.89% increase, with the full-year FY2025 number at -$37.5 million, up 19.08% from a year prior.
  • EBT hit -$11.8 million in Q4 2025 for Uxin, up from -$8.5 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $23.9 million in Q2 2022 to a low of -$266.1 billion in Q3 2021.
  • Median EBT over the past 5 years was -$7.9 million (2024), compared with a mean of -$15.7 billion.
  • Biggest five-year swings in EBT: soared 322.23% in 2022 and later plummeted 163217201.4% in 2024.
  • Uxin's EBT stood at $200158.0 in 2021, then crashed by 107.3% to -$14611.0 in 2022, then grew by 24.73% to -$10997.0 in 2023, then tumbled by 112439.78% to -$12.4 million in 2024, then rose by 4.34% to -$11.8 million in 2025.
  • The last three reported values for EBT were -$11.8 million (Q4 2025), -$8.5 billion (Q3 2025), and -$9.4 million (Q2 2025) per Business Quant data.